Can the ice-water test predict the outcome of intradetrusor injections of botulinum toxin in patients with neurogenic bladder dysfunction?
The aim of this project was to evaluate the ice-water test as a predictor of the response to intradetrusor botulinum toxin injection in patients with neurogenic detrusor overactivity. We retrospectively evaluated the urodynamic parameters in 22 patients with neurogenic bladder dysfunction and positive ice-water test. Maximum cystometric capacity (MCC), reflex volume (RV), maximum detrusor pressure during voiding (MVP) and bladder compliance (BC) were compared before and after intradetrusor injection of 300 units botulinum toxin and calculated as a quotient. The ice-water test was performed before the injection, and the maximum pressure rise and the time to maximum pressure were measured. Furthermore, the ratio between maximum pressure and time to reach maximum pressure was calculated as the velocity of pressure rise. Correlations between the ice-water test criteria and the quotients of the cystometric data before and after injection were determined by the Spearmen's Rho coefficient. The increase in MCC and RV after botulinum toxin A injection showed a small positive, but insignificant correlation of 0.25 and 0.2 to the velocity of pressure rise of the ice-water test. A small negative, but insignificant correlation was found in change of BC and MVP with -0.17 and -0.2, respectively. Based on our population the ice-water test cannot predict the efficacy of intradetrusor botulinum toxin injections in patients with neurogenic detrusor overactivity.
Huwyler
Mirjam
M
Neuro-Urology, Swiss Paraplegic Center, Balgrist University Hospital, Forchstrasse 340, 8008 Zurich, Switzerland.
Schurch
Brigitte
B
Knapp
Peter A
PA
Reitz
André
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000494:pharmacology; D003080:Cold Temperature; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage* / Q000494:pharmacology; D011237:Predictive Value of Tests; D012189:Retrospective Studies; D018709:Statistics, Nonparametric; D016896:Treatment Outcome; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy* / Q000503:physiopathology; D014563:Urodynamics / Q000187:drug effects; D014867:Water
D009465:Neuromuscular Agents; D014867:Water; D019274:Botulinum Toxins, Type A
Urol Int. 1997;58(2):84-7
9096268
Urology. 2005 Jun;65(6):1064-9
15893811
World J Urol. 1996;14 Suppl 1:S51-4
8738412
Neurourol Urodyn. 2002;21(3):261-74
11948720
N Engl J Med. 2000 Mar 2;342(9):665
10702067
J Urol. 2005 Jul;174(1):196-200
15947626
J Urol. 1998 Jul;160(1):34-8
9628600
J Urol. 2000 Sep;164(3 Pt 1):692-7
10953127
Br J Urol. 1997 May;79(5):698-701
9158504
AMA Arch Neurol Psychiatry. 1957 Oct;78(4):339-54
13457509
Eur Urol. 2004 Apr;45(4):510-5
15041117
J Urol. 2000 Oct;164(4):1280-4
10992381
J Urol. 1999 Dec;162(6):1890-6
10569531
Br J Urol. 1994 May;73(5):498-503
8012770
Br J Urol. 1997 Feb;79(2):163-7
9052463
Br J Urol. 1993 Jun;71(6):681-5
8343894
Eur Urol. 2006 Apr;49(4):644-50
16426734
J Urol. 2003 May;169(5):1896-900
12686869